Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product(Reagents, Kits, Consumables, Instruments), By Test(Laboratory, POC), By Technology(Immunodiagnostics, Microbiology, PCR, NGS), By Disease(COVID-19, Hepatitis, HAI, HIV), By End-user(Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2215 | Region: Global | Published Date: February, 2024
Pages: 242 |Tables: 154 |Figures: 77

Infectious Disease Diagnostics Market Insights

Infectious Disease Diagnostics Market size was valued at USD 27850.14 million in 2019 and is poised to grow from USD 29632.56 million in 2023 to USD 49041.76 million by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

Diagnostic tests are critical for disease diagnosis and for improving global health. Traditional infectious disease diagnosis yielded inaccuracies and was time-consuming. Because of this flaw, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. POC testing allows for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies.

US Infectious Disease Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 27850.14 million

Largest Segment

Immunodiagnostics

Fastest Growth

Immunodiagnostics

Growth Rate

6.5% CAGR

Global Infectious Disease Diagnostics, Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)

To get more reports on the above market click here to Buy The Report

Infectious Disease Diagnostics Market Segmental Analysis

The Global Infectious Disease Diagnostics Market is segmented based on Product, Test, Technology, Disease, End-User, and Region. Based on Product market is segmented into Reagents, Kits, Consumables, Instruments, and Software & Services. Based on Test Type it is categorized into Laboratory and POC. Based on Technology the Infectious Disease Diagnostics Market is segmented into Immunodiagnostics, Microbiology, PCR, NGS, and INAAT. By Disease the market is categorized into COVID-19, Hepatitis, HAI, HIV, Influenza, CT/NG, HPV, TB, and Other Infectious Diseases. By End User, the Infectious Disease Diagnostics Market studied is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users. Based on the Region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Infectious Disease Diagnostics Market Analysis by Product

The reagents, kits, and consumables segment held the largest share of this market in 2021. This segment's market growth is driven by the frequent purchase of these products due to their frequent usage. The global prevalence of infectious diseases and the onset of COVID-19, as well as growing awareness for early disease diagnosis, a shift in focus from centralized laboratories to decentralized POC testing, and rising technological advancements are driving the Infectious Disease Diagnostics Market growth.

Infectious Disease Diagnostics Market Analysis by Technology

The immunodiagnostics segment held the largest share in 2021. This is due to the increased use of immunoassays in COVID-19 testing, point-of-care infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation. The growth is attributed to an increase in the number of genomic projects, a surge in DNA sequencing awareness, and advancements in R&D for DNA analysis activities.

Global Infectious Disease Diagnostics Market By Technology, 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Infectious Disease Diagnostics Market Regional Insights

North America held the largest share of the global infectious disease diagnostics market in 2021. The growth of the North American infectious disease diagnostics market can be attributed to the highly developed healthcare systems in the United States and Canada, the presence of many leading national clinical laboratories, and the ease of access to technologically advanced instruments. Within North America, the United States has held a large market share. The increasing prevalence of infectious diseases, high healthcare expenditure, and increased population awareness about the availability of treatment devices are the major factors driving the Infectious Disease Diagnostics Market growth.

Global Infectious Disease Diagnostics Market By Geography, 2021-2028
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Infectious Disease Diagnostics Market Dynamics

Infectious Disease Diagnostics Market Driver

  • The prevalence of infectious diseases in developed and developing regions will have a positive impact on the infectious disease diagnostics market. The increasing number of prescriptions for infectious disease diagnostic tests is attributable to the diagnosis and management of such diseases. These factors, combined with the growing trend toward preventive medicine, are expected to drive demand for infectious disease diagnostics over the forecast period.
  • The increasing prevalence of infectious diseases, the shift in focus from centralized laboratories to point-of-care testing, and increased R&D activities on infectious disease diagnostics are the major factors driving the Infectious Disease Diagnostics Market growth. Scientific R&D activities in developing novel technologies and techniques such as mass spectrometry and next-generation sequencing (NGS) are changing the way rapid diagnostics are performed to detect diseases, which is contributing to Infectious Disease Diagnostics Market growth.
  • Developing economies such as India, South Korea, Brazil, and Mexico are expected to provide opportunities for growth for major players in the infectious disease diagnostics market. This can be attributed to these countries' high disease prevalence, large patient population, improved healthcare infrastructure, rising disposable income, and growing medical tourism.

Infectious Disease Diagnostics Market Restraint

  • Inadequate reimbursement is a major impediment to the infectious disease diagnostics market's growth. Most diagnostic companies face a significant challenge in commercializing their tests: getting health insurers to pay for them. Moreover, in developing countries, a large proportion of the global population is infected with infectious diseases such as HIV, malaria, and tuberculosis. Lack of training among clinicians and poor product accessibility due to lower per capita expenditure have resulted in lower adoption of POC kits in low-middle income countries.

Request Free Customization of this report to help us to meet your business objectives.

Infectious Disease Diagnostics Market Competitive Landscape

The Infectious Disease Diagnostics Market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the Infectious Disease Diagnostics Market are Veracyte Inc., Abbott Laboratories Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson, and Company.

Infectious Disease Diagnostics Market Top Player’s Company Profiles

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid Inc. (a Danaher Corporation Company)
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Bruker Corporation
  • DiaSorin S.p.A.
  • Grifols S.A.
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Nanosphere Inc.
  • Quidel Corporation

Infectious Disease Diagnostics Market Recent Developments

  • In May 2022, The U.S. Food and Drug Administration (FDA) has granted Abbott emergency use authorisation (EUA) for the fastest available molecular point-of-care test for the detection of new coronavirus (COVID-19), which provides positive findings in as little as five minutes and negative results in 13 minutes.
  • In May 2022, Quidel Corporation a US-based company that provides rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, has acquired Ortho Clinical Diagnostics and the succeeding business groups.
  • In May 2021, Torus Biosystems revealed the USD 25 million series A financing to advance infectious disease diagnostics across healthcare settings.

Infectious Disease Diagnostics Key Market Trends

  • Despite the enormous efforts put into infectious disease management, the development of low-cost, accurate, and sensitive POC products is in high demand. Nanotechnology has paved the way for widespread use in the healthcare industry. Several players have emphasized the introduction of POC platforms based on nanoparticles and Nanodevices.
  • Nanoparticles have a high surface area to volume ratio, they are suitable for a wide range of applications. To obtain real-time results for patients, disease diagnosis can be done with a small volume of samples in kits prepared using nanotechnology. As a result, nanotechnology application for infectious disease diagnosis provides reliable and rapid results.
  • Increased prevalence of infectious diseases such as hepatitis, influenza, COVID-19, and human immunodeficiency virus (HIV); increased demand for point-of-care diagnostic tests; increased funding for diagnostic service centers from private and government organizations; and technological advancements in the field of infectious disease diagnostics.

Infectious Disease Diagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the increasing prevalence of influenza and related chronic diseases, increased research and development activities in infectious disease diagnostics technologies, growing awareness for early detection using specific diagnostic tests, and other factors are driving the Global Infectious Disease Diagnostics Market. Developing economies such as India, South Korea, Brazil, and Mexico are expected to provide opportunities for growth for major players in the infectious disease diagnostics market. This can be attributed to these countries' high disease prevalence, large patient population, improved healthcare infrastructure, rising disposable income, and growing medical tourism.

Report Metric Details
Market size value in 2019 USD 27850.14 million
Market size value in 2031 USD 49041.76 million
Growth Rate 6.5%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Product
    • Reagents, Kits, Consumables, Instruments, Software & Services
  • Test
    • Laboratory, POC
  • Technology
    • Immunodiagnostics, Microbiology, PCR, NGS, INAAT
  • Disease
    • COVID-19, Hepatitis, HAI, HIV, Influenza, CT/NG, HPV, TB, Other Infectious Diseases
  • End-user
    • Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid Inc. (a Danaher Corporation Company)
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Bruker Corporation
  • DiaSorin S.p.A.
  • Grifols S.A.
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Nanosphere Inc.
  • Quidel Corporation
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Infectious Disease Diagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Infectious Disease Diagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Infectious Disease Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Infectious Disease Diagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Infectious Disease Diagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Infectious Disease Diagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Infectious Disease Diagnostics Market size was valued at USD 27850.14 million in 2019 and is poised to grow from USD 29632.56 million in 2023 to USD 49041.76 million by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The Infectious Disease Diagnostics Market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the Infectious Disease Diagnostics Market are Veracyte Inc., Abbott Laboratories Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson, and Company. 'Abbott Laboratories', 'Becton, Dickinson and Company', 'bioMérieux SA', 'Bio-Rad Laboratories, Inc.', 'Cepheid Inc. (a Danaher Corporation Company)', 'F. Hoffmann-La Roche Ltd', 'Hologic, Inc.', 'Meridian Bioscience, Inc.', 'Qiagen N.V.', 'Siemens Healthineers AG', 'Thermo Fisher Scientific Inc.', 'Alere Inc.', 'Bruker Corporation', 'DiaSorin S.p.A.', 'Grifols S.A.', 'Luminex Corporation', 'Myriad Genetics, Inc.', 'Nanosphere Inc.', 'Quidel Corporation'

The prevalence of infectious diseases in developed and developing regions will have a positive impact on the infectious disease diagnostics market. The increasing number of prescriptions for infectious disease diagnostic tests is attributable to the diagnosis and management of such diseases. These factors, combined with the growing trend toward preventive medicine, are expected to drive demand for infectious disease diagnostics over the forecast period.

Despite the enormous efforts put into infectious disease management, the development of low-cost, accurate, and sensitive POC products is in high demand. Nanotechnology has paved the way for widespread use in the healthcare industry. Several players have emphasized the introduction of POC platforms based on nanoparticles and Nanodevices.

North America held the largest share of the global infectious disease diagnostics market in 2021. The growth of the North American infectious disease diagnostics market can be attributed to the highly developed healthcare systems in the United States and Canada, the presence of many leading national clinical laboratories, and the ease of access to technologically advanced instruments. Within North America, the United States has held a large market share. The increasing prevalence of infectious diseases, high healthcare expenditure, and increased population awareness about the availability of treatment devices are the major factors driving the Infectious Disease Diagnostics Market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35G2215

$5,300
BUY NOW GET FREE SAMPLE